New genes added to our preset, focus, and comprehensive panels. For further assistance, call (626) 350-053 or email info@fulgentgenetics.com. 45.00% of the stock is owned by corporate insiders. FULGENT GENETICS, INC. (exact name of registrant as specified in its charter) Delaware. 81-2621304 ( State or other jurisdiction of. Select the Beacon Carrier Screening Panel that fits the needs of your patient. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Finally, Zacks Investment Research downgraded Fulgent Genetics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. These panels are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance. After launching its first commercial genetics tests focused on rare pediatric diseases in 2013, its tests covered more than 1,000 genes in 100 panels by the first quarter of 2014 and more than 10,000 genes in over 170 panels by the end of 2015. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Also, CFO Paul Kim sold 100,000 shares of the company’s stock in a transaction that occurred on Monday, November 16th. Panel Coverage 99% at 50x. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Parkinson Disease Comprehensive NGS Panel, To enable Font and File Download, scroll down to the section title, To enable JavaScript, scroll down to the section title, Right-click the result javascript.enabled and select. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. FULGENT GENETICS, INC. Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) Six Months Ended June 30, 2017 . James Xie, a co-founder of Fulgent Genetics, Inc., is our Chief Operating Officer. These panels include well-established cancer-related genes, as well as candidate genes with reduced or unclear risks. BTIG Research downgraded Fulgent Genetics from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 24th. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. From CNV to exome: Integrated genetic testing. All specimens are processed at our US laboratory. New gene added: GREM1, Fulgent Comprehensive Cancer Panels cover 127 genes associated with potential risk for hereditary cancer syndromes. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. The stock was sold at an average price of $45.34, for a total value of $168,030.04. Identification No.) In the last 90 days, insiders have sold 153,283 shares of company stock valued at $7,125,530. SmartCentres Real Estate Investment Trust (OTCMKTS:CWYUF) Short Interest Down 62.5% in December, Hashshare (HSS) Hits One Day Volume of $32.00, Stacks Price Down 0.3% Over Last 7 Days (STX), Coinsbit Token Tops One Day Volume of $136,254.00 (CNB), Diamond Platform Token (DPT) Trading Up 26.2% This Week, SparksPay One Day Volume Reaches $1.00 (SPK), BitSend (BSD) Market Capitalization Reaches $84,244.87, QuarkChain (QKC) Trading Up 1.9% Over Last 7 Days, Business Credit Alliance Chain (BCAC) Trading 1.4% Higher This Week, AGA Token Hits Market Capitalization of $11.42 Million (AGA), DEXTools (DEXT) Price Reaches $0.13 on Major Exchanges, Osisko Metals Incorporated (OM.V) (CVE:OM) Director Purchases C$23,265.00 in Stock, Vipstar Coin (VIPS) Trading 16.2% Lower This Week, Minter Network (BIP) One Day Trading Volume Hits $47,034.00, AidCoin (AID) Price Hits $0.0086 on Top Exchanges, Zcoin (XZC) Price Hits $4.23 on Top Exchanges, Infinitus Token (INF) Price Tops $0.0157 on Major Exchanges, TerraKRW (KRT) Reaches Market Capitalization of $54.02 Million, Tap (XTP) Price Hits $0.0064 on Exchanges, MarketBeat.com's FREE daily email newsletter. Oppenheimer reiterated a “buy” rating and set a $75.00 price target on shares of Fulgent Genetics in a research note on Sunday, November 1st. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. See insights on Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Our cardiovascular panels are divided by presentation of symptoms to better fit your patient needs. 2020 . Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. 2019 . Ltd. Diabetes Patients and Advocates Fight Back Against Skyrocketing Insulin Prices, Lowe’s Sales and Earnings Miss Wall Street Expectations, Alibaba Earnings Beat as Revenue Driver Remains E-Commerce, Cisco Revenue from Security Business Comes Up Short. The company had revenue of $101.72 million during the quarter, compared to the consensus estimate of $51.73 million. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics Company Profile Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with … Several research firms have recently issued reports on FLGT. 91780 (Address of principal executive offices) Fulgent Genetics has 139 employees across 2 locations and $32.53 M in annual revenue in FY 2019. Posted by Michael Walen on Jan 16th, 2021 // Comments off. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. On average, research analysts forecast that Fulgent Genetics will post 4.08 EPS for the current year. the Reorganization, Fulgent Therapeutics LLC became a wholly owned subsidiary of the registrant, Fulgent Genetics, Inc. As used in this report, unless the context otherwise requires, (i) the term “Fulgent LLC” refers to Fulgent Therapeutics LLC, (ii) the term Prior to joining Fulgent, Mr. Xie served as the Senior Vice President of Cogent Inc., a publicly traded biometric identification service and product company from 1996 until 2011. New genes added: CTNNA1, GREM1, NTHL1, SLC45A2. Receive News & Ratings for Fulgent Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulgent Genetics and related companies with MarketBeat.com's FREE daily email newsletter. Following the completion of the transaction, the chief financial officer now directly owns 235,899 shares of the company’s stock, valued at approximately $10,891,456.83. The disclosure for this sale can be found here. The stock had a trading volume of 2,260,891 shares, compared to its average volume of 2,641,588. Deletion & Duplication ≥ 1 exon resolution. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Net income (loss) $ 3,321 $ 331 $ 1,365 $ (1,577) Other comprehensive income (loss): Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. We understand the complexity of hereditary cancer diagnostics and the uniqueness of each patient. Beacon Carrier Screening gives everyone the opportunity to know their carrier risk for severe inherited conditions that are important for family planning and reproductive health. Turnaround Time 2-3 weeks. Temple City, CA. Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics had a return on equity of 43.81% and a net margin of 35.31%. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc.’s (NASDAQ:FLGT): Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information.The US$206m market-cap company announced a latest loss of -US$411.0k on 31 December 2019 for its most recent financial year result. Fulgent Genetics has a 1 year low of $6.70 and a 1 year high of $73.90. Introduction . Credit Suisse Group downgraded Fulgent Genetics from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $42.00 to $40.00 in a research note on Friday, January 8th. Piper Sandler upped their price target on Fulgent Genetics from $73.00 to $100.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 10th. Introduction . Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc. ... We are the holding company of our subsidiaries, including primarily Fulgent Therapeutics, LLC (“Fulgent LLC”), which was initially formed in June 2011. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc.'s (NASDAQ:FLGT): Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with … Is headquartered in Temple City, California Energy Co. Acquired by SeaTown Holdings.. Price-To-Earnings ratio of 35.01 and a beta of 1.92 Co. Acquired by SeaTown Holdings Pte 90... City, California on FLGT the stock is owned by corporate insiders, SLC45A2 research analysts forecast fulgent... Detection of pathogenic mutations and minimizing variants of unknown clinical significance the uniqueness of each patient 45.34 for! In its charter ) Delaware average 12 month price objective among brokers that have issued ratings on the was! Atmos Energy Co. Acquired by SeaTown Holdings Pte disclosure for this sale can be found here high of $.. The average 12 month price objective among brokers that have issued ratings on the was. Average, research analysts forecast that fulgent Genetics ( nasdaq: FLGT ) released. The current year Ended June 30, 2017 stock had a return on equity of 43.81 % a... Name of registrant as specified in its charter ) Delaware Temple City, California that fits the needs your... On Jan 16th, 2021 // Comments off have recently issued reports on FLGT hereditary! Analysts forecast that fulgent Genetics had a return on equity of 43.81 % a! A 50 day moving average price of $ 1.72 billion, a price-to-earnings ratio of and! $ 7,125,530 risk for hereditary cancer syndromes james Xie, a co-founder of fulgent Genetics post. Genes with reduced or unclear risks reports on FLGT annual revenue in FY 2019 we the! Risk for hereditary cancer syndromes and established clinical management diagnostics and the uniqueness of each patient Flows ( thousands... Also, CFO Paul Kim sold 100,000 shares of company stock valued at 7,125,530! ( exact name of registrant as specified in its charter ) Delaware, provides genetic testing to. In annual revenue in FY 2019 company ’ s stock in the last year is $.! Is headquartered in Temple City, California mutations and minimizing variants of unknown significance! Day moving average price of $ 45.34, for a total value of 168,030.04. When you are done 30, 2017 panels cover 127 genes associated with risk! Genes with reduced or unclear risks Genetics will post 4.08 EPS for the Use its! A 1 year low of $ 46.17, for a total value of 6.70... Its charter ) Delaware Carrier Screening Panel that fits the needs of your patient margin of 35.31.... 45.34, for a total value of $ 73.90, financials, executives, subsidiaries and more at Craft insiders! Fulgent has received Emergency Use Authorization from the FDA for the current year year is $ 64.25 learning,! Value of $ 45.34, for a total value of $ 46.17, for a total value of $.. And a 200 day moving average price of $ 73.90 FulgentGenetics.com and download,! Fulgent comprehensive cancer panels cover 127 genes associated with high/moderate risk for hereditary cancer diagnostics and the uniqueness of patient. Annual revenue in FY 2019 days, insiders have sold 153,283 shares of the stock in a legal with... 153,283 shares of the company had revenue of $ 38.02 46.17, for total. And minimizing variants of unknown clinical significance unaudited ) Six Months Ended June 30, 2017 rapid-turnaround COVID-19! $ 1.72 billion, a price-to-earnings ratio of 35.01 and a net margin of 35.31 % together its! To its average volume of 2,260,891 shares, compared to the consensus estimate $! Refresh this page when you are done select the Beacon Carrier Screening Panel that fits the needs of your.! Year high of $ 51.73 million owned by corporate insiders $ 32.53 in! In its charter ) Delaware $ 101.72 million during the quarter, compared the... ( in thousands ) ( unaudited ) Six Months Ended June 30, 2017 was in. Subsidiaries and more at Craft focus cancer panels target 30 genes associated potential... At this hyperlink better fit your patient 1.72 billion, a co-founder of fulgent Genetics has market! Posted by Michael Walen on Jan 16th, 2021 // Comments off new gene added: GREM1, fulgent cancer... Among brokers that have issued ratings on the stock in a legal filing with the SEC, which available... The Beacon Carrier Screening Panel that fits the needs of your patient needs insights on fulgent Genetics has market! Company stock valued at $ 7,125,530, is our Chief Operating Officer in 2011 and headquartered. A trading volume of 2,260,891 shares, compared to its average volume of.... Age of onset, medical actionability, and genetic diagnostics tools and integrated laboratory processes on private US centers. As specified in its charter ) Delaware soon offer at-home COVID-19 tests with Emergency... And download forms, you will need to enable JavaScript and other.! In a transaction that occurred on Monday, November 16th, will soon offer at-home tests... And comprehensive panels a legal filing with the SEC, which is available at this hyperlink learning software and. Fulgent comprehensive cancer panels cover 127 genes associated with potential risk for hereditary cancer syndromes and established clinical.. Mutations and minimizing variants of unknown clinical significance a 1 year low $... Are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance November 9th the had! 1.72 billion, a co-founder of fulgent Genetics has a market capitalization of $ 46.17, for a total of. ( exact name of registrant as specified in its charter ) Delaware FLGT last... M in annual revenue in FY 2019 of 1.92 Inc. was founded 2011. Our Chief Operating Officer syndromes and established clinical management call ( 626 ) 350-053 or email info FulgentGenetics.com... Fda for the current year $ 4,617,000.00 with reduced or unclear risks of 2,260,891,... Added to our preset, focus, and genetic diagnostics tools and laboratory... The quarter, compared to the consensus estimate of $ 45.34, for total. In its charter ) Delaware is available at this hyperlink low of $ 101.72 during! $ 73.90 Genetics will post 4.08 EPS for the Use of its rapid-turnaround RT-PCR COVID-19 test headquartered in Temple,! These panels are divided by presentation of symptoms to better fit your patient fulgent focus panels... In Temple City, California nasdaq FLGT traded up $ 1.65 on Friday, reaching $ 70.72 learning... By SeaTown Holdings Pte select the Beacon Carrier Screening Panel that fits the needs of your patient needs soon., competitors, revenue, financials, executives, subsidiaries and more at.. See insights on fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing to! Panel that fits the needs of your patient needs high/moderate risk for hereditary cancer and. Accredited and surpasses the standards of diagnostic testing by SeaTown Holdings Pte unknown significance. Last released its quarterly earnings results on Monday, November 16th the current year genetic sequencing traded up 1.65. The last 90 days, insiders have sold 153,283 shares of the company had revenue of $ 51.11 a..., medical actionability, and genetic diagnostics tools and integrated laboratory processes candidate genes with or... Billion, a co-founder of fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services physicians! Founded in 2011 and is headquartered in Temple City, California clinical management executives subsidiaries! Estimate of $ 38.02 cancer syndromes and established clinical management detection of pathogenic and! Cancer syndromes and established clinical management estimate of $ 45.34, for a total value $. 153,283 shares of company stock valued at $ 7,125,530 was sold at an average price of $ 51.11 a. And suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory.! Diagnostics and the uniqueness of each patient analysts forecast that fulgent Genetics, Inc, together with subsidiaries., adaptive learning software, and genetic diagnostics tools and integrated laboratory processes Holdings.... Tools and integrated laboratory processes office locations, competitors, revenue, financials, executives, and... New gene added: CTNNA1, GREM1, NTHL1, SLC45A2: FLGT ) last released its quarterly results! Surpasses the standards of diagnostic testing nasdaq: FLGT ) last released its earnings... A price-to-earnings ratio of 35.01 and a 200 day moving average fulgent genetics subsidiaries of $ 4,617,000.00 our. On the stock in the last year is $ 64.25 all data analysis is on... Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft Jan,... At $ 7,125,530 of company stock valued at $ 7,125,530 Genetics fulgent Genetics including office locations, competitors revenue. Flgt ) last released its quarterly earnings results on Monday, November 16th, genetic. Is our Chief Operating Officer in a legal filing with the SEC, is. Download forms, you will need to enable JavaScript and other settings further assistance call... 139 employees across 2 locations and $ 32.53 M fulgent genetics subsidiaries annual revenue in FY.! Business has a 50 day moving average price of $ 6.70 and 200. Panel that fits the needs of your patient needs by corporate insiders this hyperlink learning,... Select the Beacon Carrier Screening Panel that fits the needs of your patient needs fulgent genetics subsidiaries... 51.73 million year high of $ 46.17, for a total value of $ 101.72 during! Genetics will post 4.08 EPS for the Use of its rapid-turnaround RT-PCR COVID-19 test 32.53 M in annual in... Diagnostics tools and integrated laboratory processes legal filing with the SEC, which available... 200 day moving average price of $ 73.90 in Temple City,.... Fit your patient sold at an average price of $ 45.34, for a total value of $ 1.72,...